Development of [103Pd]-labeled-bis(N4- methylthiosemicarbazone) complexes as possible therapeutic agents

Radiochimica Acta

Volumn 94, Issue 12, 2006, Pages 865-869

  Jalilian, A R ^a   Sadeghi, M ^a   Kamrani, Y Y ^a  

^a ATOMIC ENERGY ORGANIZATION OF IRAN   (Iran)

Author keywords

ATSM; Bis thiosemicarbazono complexes; Cyclotron; Palladium(II) complexes; Palladium 103; PTSM; Radiolabeling; Targeted therapy

Indexed keywords

EID: 33846145674     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2006.94.12.865     Document Type: Article

References (41)

1. Meigooni, A. S., Zhang, H., Perry, C., Dini, S. A., Koona, R. A.: Theoretical and experimental determination of dosimetric characteristics for brachyseed Pd-103, model Pd-1. Appl. Radiat. Isotopes 58, 533 (2003).
2. Sherertz, T., Wallner, K., Merrick, G., Cavanagh, W., Butler, W., Reed, D., True, L.: The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 plus beam radiation therapy. Cancer 10, 301 (2004).
3. 103Pd. Appl. Radiat. Isotopes 56, 821 (2002).
4. Padhye, S., Afrasiabi, Z., Sinn, E., Fok, J., Mehta, K., Rath, N.: Antitumor metallothiosemicarbazonates: structure and antitumor activity of palladium complex of phenanthrenequinone thiosemicarbazones. Inorg. Chem. 44, 1154 (2005).
5. Chen, J., Huang, Y. W., Liu, G., Afrasiabi, Z., Sinn, E., Padhye, S., Ma, Y.: The cytotoxicity and mechanisms of 1, 2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells. Toxicol. Appl. Pharmacol. 197, 40 (2004).
6. Kovala-Demertzi, D., Domopoulou, A., Demertzis, M. A., Valle, G., Papageorgiou, A.: Palladium(II) complexes of 2-acetylpyridine N(4)-methyl, N(4)-ethyl and N(4)-phenyl-thiosemicarbazones. Crystal structure of chloro(2-acetylpyridine N(4)- methylthiosemicarbazonato) palladium(II). Synthesis, spectral studies, in vitro and in vivo antitumour activity. J. Inorg. Biochem. 68, 147 (1997).
7. Rebolledo, A. P., Vieites, M., Gambino, D., Piro, O. E., Castellano, E. E., Zani, C. L., Souza-Fagundes, E. M., Teixeira, L. R., Batista, A. A., Beraldo, H.: Palladium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones: spectral characterization, structural studies and cytotoxic activity. J. Inorg. Biochem. 99, 698 (2005).
8. Quiroga, A. G., Perez, J. M., Montero, E. I., West, D. X., Alonso, C., Navarro-Ranninger, C.: Synthesis and characterization of Pd(II) and Pt(II) complexes of p-isopropylbenzaldehyde N-protected thiosemicarbazones. Cytotoxic activity against ras-transformed cells. J. Inorg. Biochem. 75, 293 (1999).
9. Rodriguez-Arguelles, M. C., Belicchi Ferrari, M., Gasparri Fava, G., Pelizzi, C., Pelosi, G., Albertini, R., Bonati, A., Dall'Aglio, P. P., Lunghi, P., Pinelli, S.: Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. J. Inorg. Biochem. 66, 7 (1997).
10. Genova, P., Varadinova, T., Matesanz, A. I., Marinova, D., Souza, P.: Toxic effects of bis(thiosemicarbazone) compounds and its palladium(II) complexes on herpes simplex virus growth. Toxicol. Appl. Pharmacol. 197, 107 (2004).
11. Kovala-Demertzi, D., Demertzis, M. A., Miller, J. R., Frampton, C. S., Jasinski, J. P., West, D. X.: Structure of bis(2-acetylpyridine 3-hexamethyleneiminylthiosemicarbazonato) palladium II, a potential antitumor complex. J. Inorg. Biochem. 92, 137 (2002).
12. 62Cu-PTSM. J. Nucl. Med. 41, 309 (2000).
13. DeNrado, S. J.: Radioimmunodetection and therapy of breast cancer. Semin. Nucl. Med. 35, 143 (2005).
14. Shelton, M. E., Green, M. A., Mathias, C. J., Welch, M. J., Bergmann, S. R.: Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Circulation 82, 990 (1990).
15. Shelton, M. E., Green, M. A., Mathias, C. J., Welch, M. J., Bergmann, S. R.: Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. J. Nucl. Med. 30, 1843 (1989).
16. Young, H., Carnochan, P., Zweit, J., Babich, J., Cherry, S., Ott, R.: Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET. J. Nucl. Biol. Med. 38, 89 (1994).
17. Young, H., Carnochan, P., Zweit, J., Babich, J., Cherry, S., Ott R.: Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model. Eur. J. Nucl. Med. 21, 336 (1994).
18. Mathias, C. J., Welch, M. J., Perry, D. J., McGuire, A. H., Zhu, X., Connett, J. M., Green, M. A.: Investigation of copper-PTSM as a PET tracer for tumor blood flow. Nucl. Med. Biol. 18, 807 (1991).
19. 14C-iodoantipyrine. Nucl. Med. Biol. 21, 613 (1994).
20. 4- methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl. Acad. Sci. USA 99, 3030 (2002).
21. 4-methylthiosemicarbazone): An agent for radiotherapy. Proc. Natl. Acad. Sci. USA 98, 1206 (2001).
22. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J. Nucl. Med. 40, 177 (1999).
23. Fujibayashi, Y., Taniuchi, H., Yonekura, Y., Ohtani, H., Konishi, J., Yokoyama, A.: Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J. Nucl. Med. 38, 1155 (1997).
24. Fujibayashi, Y., Obata, A., Waki, A., Horiuchi, K. S., Yonekura, Y., Welch, M. J.: Physicochemical and biological basis on the selection of Cu-ATSM as hypoxia imaging agent: survey studies in vitro as well as in vivo. J. Labelled Compds. Radiopharm. 42, 279 (1999).
25. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J. Nucl. Med. 40, 177 (1999).
26. Lewis, J. S., Sharp, T. L., Laforest, R., Fujibayashi, Y., Welch, M. J.: Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J. Nucl. Med. 42, 655 (2001).
27. Mathias, C. J., Welch, M. J., Green, M. A., Diril, H., Meares, C. F., Gropler, R. J.: in vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. J. Nucl. Med. 32, 475 (1991).
28. 62Cu positron generator: perfusion and plasma pool images in normal subjects. Ann. Nucl. Med. 9, 81 (1995).
29. 62Cu-PTSM and positron emission tomography. Circulation 87, 173 (1993).
30. 103Pd]-2-Acetylpyridine 4N-methyl thiosemicarbazone complex for targeted therapy. J. Radioanal. Nucl. Chem. 268, 605 (2006).
31. 103Pd]-Bleomycin Complex for targeted therapy. Nukleonika 51, 119 (2006).
32. Sadeghi M., Van den Winkel, P., Afarideh, H., Haji-Saeid, M.: A thick rhodium electrodeposition on copper backing as the target for production of palladium-103. J. Radioanal. Nucl. Chem. 262, 665 (2004).
33. th edn., Ellis Horwood Ltd., Warsaw (1976), p. 601.
34. th Edn., official monographs, thallous chloride Tl-201 Injection (2005), Vol. 2, p. 1895.
35. 61Cu]-2-Acetylpyridine thiosemicarbazone Complex as a Possible PET tracer for malignancies. Appl. Radiat. Isotopes 64, 337 (2006).
36. 4-methylthiosemicarbazone) complex as a possible PET radiopharmaceutical. Radiochim. Acta 94, 113 (2006).
37. Quiroga, A. G., Perez, J. M., Lopez-Solera, I., Masaguer, J. R., Luque, A., Roman, P., Edwards, A., Alonso, C.: Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. J. Med. Chem. 41, 1399 (1998).
38. Iakovidou, Z., Mioglou E., Mourelatos, D., Kotsis, A., Demertzis, M. A., Papagoergiou, A., Miller, J. R., Kovala-Demertzi, D.: Cytogenetic and antineoplastic effects ofc Pt(II) and Pd(II) complexes with 2-acetylpyridine thiosemicarbazone. Anticancer Drugs 12, 65 (2001).
39. Gingras, B. A., Suprunchuk, T., Bayley, C. H.: The preparation of some thiosemicarbazones and their copper complexes, Part III. Can. J. Chem. 40, 1053 (1962).
40. Kovala-Demertzi, D., Domopoulou, A., Demertzis, M. A., Valle, G., Papageorgiou, A.: Palladium(II) complexes of 2-acetylpyridine N(4)-methyl, N(4)-ethyl and N(4)-phenyl-thiosemicarbazones. Crystal structure of chloro(2-acetylpyridine N(4)- methylthiosemicarbazonato) palladium(II). Synthesis, spectral studies, in vitro and in vivo antitumour activity. J. Inorg. Biochem. 68, 147 (1997).
41. 61Cu using proton induced nuclear reactions on zinc for PET studies. J. Radioanal. Nucl. Chem. 263(2), 539 (2005).